US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Septerna, Inc.

23.34

+0.25001.08%

Volume:218.21K

Turnover:5.06M

Market Cap:1.05B

PE:-21.22

High:24.33

Open:23.00

Low:22.83

Close:23.09

52wk High:32.63

52wk Low:5.73

Shares:44.77M

Float Shares:18.20M

Volume Ratio:0.81

T/O Rate:1.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1000

EPS(LYR):-1.1044

ROE:-12.19%

ROA:-9.59%

PB:2.74

PE(LYR):-21.13

Loading ...

Overview Company News Filings

Is Septerna (SEPN) Using Its First PTH1R Trial To Redefine Its GPCR Strategy?

Simply Wall St.

Septerna starts Phase 1 trial of SEP-479 oral hypoparathyroidism drug

Septerna Inc - Phase 1 Trial Expected to Enroll up to 150 Participants

THOMSON REUTERS

Septerna Inc - Phase 1 Trial Data Expected in Late 2026 or Early 2027

THOMSON REUTERS

Septerna Is Maintained at Overweight by JP Morgan

Should Septerna’s New ATM and Shelf Offering Strategy Require Action From Septerna (SEPN) Investors?

Simply Wall St.

Septerna (SEPN) Is Down 13.5% After Launching US$150 Million ATM Equity Program and Filing Shelves

Simply Wall St.

Stock Track | Septerna Plummets 5.05% Intraday as Q4 Losses Reinforce Profitability Concerns

Septerna (SEPN) Q4 Loss Despite Revenue Surge Reinforces Bearish Profitability Narrative

Simply Wall St.

Septerna Is Maintained at Buy by Truist Securities

Septerna price target raised to $35 from $34 at Truist

Truist Lifts Price Target on Septerna to $35 From $34, Keeps Buy Rating

MT Newswires Live

Septerna files automatic mixed securities shelf

Wells Fargo Reaffirms Their Buy Rating on Septerna, Inc. (SEPN)

Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating

Septerna reports Q4 EPS (24c), consensus (22c)

Biotech firm Septerna beats Q4 revenue expectations, net loss narrows

Earnings Flash (SEPN) Septerna Posts Q4 Loss $-0.24, vs. FactSet Est of Loss of $-0.24

MT Newswires Live

Septerna Q4 EPS $(0.24) Misses $0.03 Estimate, Sales $24.118M Miss $32.667M Estimate

Septerna Q4 revenue hits USD 24.12 million as net loss narrows 48% to USD 10.74 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SEPN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SEPN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SEPN\",,,,,undefined,":{"symbol":"SEPN","market":"US","secType":"STK","nameCN":"Septerna, Inc.","latestPrice":23.34,"timestamp":1776110400000,"preClose":23.09,"halted":0,"volume":218213,"delay":0,"changeRate":0.010827197921177999,"floatShares":18202732,"shares":44774192,"eps":-1.1,"marketStatus":"Pre-Mkt","change":0.25,"latestTime":"04-14 05:39:59 EDT","open":23,"high":24.33,"low":22.83,"amount":5059581.5328,"amplitude":0.064963,"askPrice":27.13,"askSize":100,"bidPrice":9.39,"bidSize":150,"shortable":3,"etf":0,"ttmEps":-1.1,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776173400000},"marketStatusCode":1,"adr":0,"listingDate":1729828800000,"exchange":"NASDAQ","adjPreClose":23.34,"postHourTrading":{"tag":"盘后","latestPrice":23.34,"preClose":23.34,"latestTime":"16:04 EDT","volume":6106,"amount":142514.04,"timestamp":1776110672066,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8128626041876109,"impliedVol":0.8026,"impliedVolPercentile":0.739},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SEPN\",,,,,undefined,":{"symbol":"SEPN","floatShares":18202732,"roa":"-9.59%","roe":"-12.19%","lyrEps":-1.104402,"volumeRatio":0.8128626041876109,"shares":44774192,"dividePrice":0,"high":24.33,"amplitude":0.064963,"preClose":23.09,"low":22.83,"week52Low":5.73,"pbRate":"2.74","psRate":"22.74","week52High":32.63,"institutionHeld":0,"latestPrice":23.34,"committee":0.2,"eps":-1.1,"divideRate":0,"volume":218213,"delay":0,"ttmEps":-1.1,"open":23,"prevYearClose":27.88,"prevWeekClose":23.09,"prevMonthClose":24.03,"prevQuarterClose":24.03,"fiveDayClose":24.78,"twentyDayClose":25.14,"sixtyDayClose":26.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SEPN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-09","symbol":"SEPN","fiscalQuarterEnding":"2025/12","expectedEps":-0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"post","actualEps":-0.24},{"market":"US","date":"2025-11-10","symbol":"SEPN","fiscalQuarterEnding":"2025/09","expectedEps":0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.09},{"market":"US","date":"2025-08-11","symbol":"SEPN","fiscalQuarterEnding":"2025/06","expectedEps":-0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.56},{"market":"US","date":"2025-05-15","symbol":"SEPN","fiscalQuarterEnding":"2025/03","expectedEps":-0.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-03-27","symbol":"SEPN","fiscalQuarterEnding":"2024/12","expectedEps":-0.69,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.64}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SEPN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SEPN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.875,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.875,"analysts":8,"updateTime":1766721600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SEPN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SEPN","date":"2026-04-13","current":-21.218182,"percent":0.286501,"low":-71.269737,"twenty":-22.604133,"median":-15.629568,"eighty":-5.790308,"high":261.261398,"avg":-7.503444,"sd":57.007449,"marketCap":1036888175},"quantilePoints":[{"date":"2024-10-25","current":180.873276,"twenty":180.873276,"median":180.873276,"eighty":180.873276,"marketCap":756050292},{"date":"2024-10-31","current":204.688257,"twenty":197.111676,"median":204.688257,"eighty":209.813,"marketCap":855596913},{"date":"2024-11-08","current":261.261398,"twenty":203.984861,"median":216.997688,"eighty":242.57116,"marketCap":1092072644},{"date":"2024-11-15","current":224.885772,"twenty":207.743006,"median":230.613426,"eighty":256.156752,"marketCap":940022529},{"date":"2024-11-22","current":-56.371082,"twenty":203.984861,"median":228.503238,"eighty":245.706296,"marketCap":915240881},{"date":"2024-11-29","current":-69.163916,"twenty":-57.105794,"median":221.92146,"eighty":240.581553,"marketCap":1122945345},{"date":"2024-12-06","current":-68.890433,"twenty":-66.926823,"median":208.506693,"eighty":237.707678,"marketCap":1118505070},{"date":"2024-12-13","current":-61.725172,"twenty":-67.501138,"median":191.022276,"eighty":236.763117,"marketCap":1002169886},{"date":"2024-12-20","current":-63.995083,"twenty":-66.784612,"median":-58.207863,"eighty":234.592638,"marketCap":1039024162},{"date":"2024-12-27","current":-70.449288,"twenty":-68.420042,"median":-60.166317,"eighty":232.180994,"marketCap":1143814633},{"date":"2025-01-03","current":-58.388676,"twenty":-68.655237,"median":-61.232902,"eighty":229.769351,"marketCap":947998541},{"date":"2025-01-10","current":-57.02126,"twenty":-67.714455,"median":-60.412452,"eighty":226.39305,"marketCap":925797170},{"date":"2025-01-17","current":-46.437457,"twenty":-67.358927,"median":-58.853597,"eighty":224.885772,"marketCap":753958559},{"date":"2025-01-24","current":-50.266223,"twenty":-66.593173,"median":-57.614562,"eighty":220.142874,"marketCap":816122397},{"date":"2025-01-31","current":-48.433885,"twenty":-66.401735,"median":-55.982023,"eighty":215.822012,"marketCap":786372560},{"date":"2025-02-07","current":-38.861971,"twenty":-65.110894,"median":-50.840537,"eighty":209.813,"marketCap":630962963},{"date":"2025-02-14","current":-31.587316,"twenty":-64.153703,"median":-49.199638,"eighty":205.451944,"marketCap":512851670},{"date":"2025-02-21","current":-16.108164,"twenty":-63.748948,"median":-46.492154,"eighty":202.578068,"marketCap":261532150},{"date":"2025-02-28","current":-15.862029,"twenty":-63.55204,"median":-46.410109,"eighty":188.992476,"marketCap":257535903},{"date":"2025-03-07","current":-17.393535,"twenty":-63.169163,"median":-46.191322,"eighty":63.291545,"marketCap":282401439},{"date":"2025-03-14","current":-17.47558,"twenty":-62.928498,"median":-43.237703,"eighty":-15.145503,"marketCap":283733521},{"date":"2025-03-21","current":-16.81922,"twenty":-62.747999,"median":-39.764466,"eighty":-15.424456,"marketCap":273076863},{"date":"2025-03-28","current":-3.893469,"twenty":-62.08617,"median":-37.439858,"eighty":-15.424456,"marketCap":279543299},{"date":"2025-04-04","current":-3.590162,"twenty":-61.462628,"median":-35.44343,"eighty":-3.701581,"marketCap":257766476},{"date":"2025-04-11","current":-3.194007,"twenty":-61.271189,"median":-31.04035,"eighty":-3.397655,"marketCap":229323279},{"date":"2025-04-17","current":-3.707771,"twenty":-61.249311,"median":-18.610536,"eighty":-3.429843,"marketCap":266210551},{"date":"2025-04-25","current":-3.998698,"twenty":-60.904722,"median":-17.913153,"eighty":-3.49979,"marketCap":287098524},{"date":"2025-05-02","current":-4.419614,"twenty":-60.313998,"median":-17.530277,"eighty":-3.557975,"marketCap":317319421},{"date":"2025-05-09","current":-4.302005,"twenty":-59.827198,"median":-17.393535,"eighty":-3.586448,"marketCap":308875347},{"date":"2025-05-16","current":-5.700187,"twenty":-58.946582,"median":-17.1474,"eighty":-3.607494,"marketCap":450930380},{"date":"2025-05-23","current":-5.339701,"twenty":-58.316351,"median":-16.81922,"eighty":-3.64092,"marketCap":422413044},{"date":"2025-05-30","current":-5.553739,"twenty":-57.970542,"median":-16.682479,"eighty":-3.660728,"marketCap":439345212},{"date":"2025-06-06","current":-5.925491,"twenty":-56.891224,"median":-16.203883,"eighty":-3.697867,"marketCap":468753715},{"date":"2025-06-13","current":-5.863532,"twenty":-56.29327,"median":-16.053467,"eighty":-3.717675,"marketCap":463852298},{"date":"2025-06-20","current":-5.908593,"twenty":-55.982023,"median":-15.862029,"eighty":-3.757291,"marketCap":467416965},{"date":"2025-06-27","current":-6.122632,"twenty":-53.001056,"median":-15.383433,"eighty":-3.77586,"marketCap":484349134},{"date":"2025-07-03","current":-6.404261,"twenty":-51.513306,"median":-10.750269,"eighty":-3.795668,"marketCap":506628303},{"date":"2025-07-11","current":-6.578872,"twenty":-50.660039,"median":-6.404261,"eighty":-3.874899,"marketCap":520441387},{"date":"2025-07-18","current":-7.108336,"twenty":-50.32092,"median":-6.590137,"eighty":-3.893469,"marketCap":562326225},{"date":"2025-07-25","current":-7.6378,"twenty":-49.412955,"median":-6.753482,"eighty":-3.9727,"marketCap":604211063},{"date":"2025-08-01","current":-6.990051,"twenty":-48.587036,"median":-6.961888,"eighty":-3.99746,"marketCap":552968974},{"date":"2025-08-08","current":-6.590137,"twenty":-46.8805,"median":-6.764747,"eighty":-3.998698,"marketCap":521332554},{"date":"2025-08-15","current":-5.951139,"twenty":-46.492154,"median":-6.643647,"eighty":-4.11805,"marketCap":520754376},{"date":"2025-08-22","current":-5.961329,"twenty":-46.448396,"median":-6.601402,"eighty":-4.167728,"marketCap":521646079},{"date":"2025-08-29","current":-6.256848,"twenty":-46.3937,"median":-6.581688,"eighty":-4.266238,"marketCap":547505457},{"date":"2025-09-05","current":-7.194356,"twenty":-46.300716,"median":-6.581688,"eighty":-4.297053,"marketCap":629542106},{"date":"2025-09-12","current":-7.34721,"twenty":-46.213201,"median":-6.601402,"eighty":-4.305719,"marketCap":642917646},{"date":"2025-09-19","current":-8.121674,"twenty":-44.993466,"median":-6.643647,"eighty":-4.319893,"marketCap":710687051},{"date":"2025-09-26","current":-8.534381,"twenty":-43.94876,"median":-6.764747,"eighty":-4.33085,"marketCap":746801011},{"date":"2025-10-03","current":-10.266733,"twenty":-43.12831,"median":-6.961888,"eighty":-4.351524,"marketCap":898390470},{"date":"2025-10-10","current":-11.790184,"twenty":-42.592283,"median":-7.068908,"eighty":-4.39733,"marketCap":1031700023},{"date":"2025-10-17","current":-11.497212,"twenty":-40.869338,"median":-7.146788,"eighty":-4.427042,"marketCap":1006063571},{"date":"2025-10-24","current":-11.102338,"twenty":-39.518331,"median":-7.194356,"eighty":-4.55084,"marketCap":971510091},{"date":"2025-10-31","current":-10.949483,"twenty":-39.058879,"median":-7.339567,"eighty":-4.913908,"marketCap":958134551},{"date":"2025-11-07","current":-9.578887,"twenty":-37.155435,"median":-7.357401,"eighty":-5.147066,"marketCap":838200538},{"date":"2025-11-14","current":-14.648361,"twenty":-35.886473,"median":-7.487327,"eighty":-5.196633,"marketCap":861455454},{"date":"2025-11-21","current":-18.097273,"twenty":-35.585642,"median":-7.6378,"eighty":-5.267603,"marketCap":1064282543},{"date":"2025-11-28","current":-22.094357,"twenty":-33.900984,"median":-7.78988,"eighty":-5.319423,"marketCap":1299347051},{"date":"2025-12-05","current":-19.916898,"twenty":-31.401348,"median":-8.060532,"eighty":-5.378003,"marketCap":1171292862},{"date":"2025-12-12","current":-19.954966,"twenty":-31.056759,"median":-8.182815,"eighty":-5.451226,"marketCap":1173531572},{"date":"2025-12-19","current":-20.96756,"twenty":-27.412726,"median":-8.753473,"eighty":-5.501919,"marketCap":1233081247},{"date":"2025-12-26","current":-22.436964,"twenty":-22.503963,"median":-9.413294,"eighty":-5.544727,"marketCap":1319495438},{"date":"2026-01-02","current":-21.226419,"twenty":-22.436964,"median":-9.632386,"eighty":-5.553739,"marketCap":1248304472},{"date":"2026-01-09","current":-19.597131,"twenty":-22.436964,"median":-9.915167,"eighty":-5.569002,"marketCap":1152487702},{"date":"2026-01-16","current":-20.845744,"twenty":-22.436964,"median":-10.381374,"eighty":-5.593168,"marketCap":1225917376},{"date":"2026-01-23","current":-20.305186,"twenty":-22.162878,"median":-10.567347,"eighty":-5.611192,"marketCap":1194127700},{"date":"2026-01-30","current":-18.120114,"twenty":-22.094357,"median":-10.857771,"eighty":-5.615698,"marketCap":1065625769},{"date":"2026-02-06","current":-18.607377,"twenty":-21.850725,"median":-11.071767,"eighty":-5.615698,"marketCap":1094281252},{"date":"2026-02-13","current":-19.612358,"twenty":-21.722819,"median":-11.209336,"eighty":-5.64356,"marketCap":1153383185},{"date":"2026-02-20","current":-20.61734,"twenty":-21.739568,"median":-11.372381,"eighty":-5.676942,"marketCap":1212485119},{"date":"2026-02-27","current":-23.053657,"twenty":-22.094357,"median":-11.478105,"eighty":-5.697934,"marketCap":1355762533},{"date":"2026-03-06","current":-20.914266,"twenty":-22.094357,"median":-11.754518,"eighty":-5.704017,"marketCap":1229947054},{"date":"2026-03-13","current":-24.295691,"twenty":-22.288862,"median":-11.879349,"eighty":-5.719638,"marketCap":1187549060},{"date":"2026-03-20","current":-22.30665,"twenty":-22.436964,"median":-13.780423,"eighty":-5.741868,"marketCap":1090326760},{"date":"2026-03-27","current":-22.729264,"twenty":-22.436964,"median":-14.644554,"eighty":-5.761019,"marketCap":1110983692},{"date":"2026-04-02","current":-22.389336,"twenty":-22.436964,"median":-14.872318,"eighty":-5.77679,"marketCap":1094368334},{"date":"2026-04-10","current":-22.811949,"twenty":-22.645844,"median":-15.588546,"eighty":-5.790308,"marketCap":1115025266},{"date":"2026-04-13","current":-21.213367,"twenty":-22.604133,"median":-15.629568,"eighty":-5.790308,"marketCap":1036888175}],"updateTime":1776155981128},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SEPN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627545758","title":"Is Septerna (SEPN) Using Its First PTH1R Trial To Redefine Its GPCR Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2627545758","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627545758?lang=en_us&edition=fundamental","pubTime":"2026-04-13 23:20","pubTimestamp":1776093656,"startTime":"0","endTime":"0","summary":"Septerna, Inc. recently began dosing healthy adult volunteers in a Phase 1 single- and multiple-ascending dose clinical trial of SEP-479, an oral small molecule PTH1R agonist being developed for hypoparathyroidism.\nThis marks a key progression of Septerna’s GPCR-targeted pipeline into human testing, with initial safety, PK and PD data expected in late 2026 or early 2027.\nNext, we’ll examine how initiating human dosing for SEP-479 and its focus on hypoparathyroidism could shape Septerna’s...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/is-septerna-sepn-using-its-first-pth1r-trial-to-redefine-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/is-septerna-sepn-using-its-first-pth1r-trial-to-redefine-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SEPN","GPCR","BK4007","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627307394","title":"Septerna starts Phase 1 trial of SEP-479 oral hypoparathyroidism drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2627307394","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627307394?lang=en_us&edition=fundamental","pubTime":"2026-04-13 20:04","pubTimestamp":1776081891,"startTime":"0","endTime":"0","summary":"Results have not been presented; Phase 1 data are expected in late 2026 or early 2027.Study will assess whether SEP-479 can be taken safely and support calcium control with once-daily dosing.Trial is designed to enroll up to 150 healthy adults across single-ascending dose and multiple-ascending dose cohorts.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL7nMxQQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4588","IE00BGHQF748.EUR","NDAQ","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU0314104364.USD","LU2095319765.USD","BK4112","SG9999014005.SGD","BK4007","SG9999014021.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","SEPN","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SG9999014039.USD","BK4585","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627300634","title":"Septerna Inc - Phase 1 Trial Expected to Enroll up to 150 Participants","url":"https://stock-news.laohu8.com/highlight/detail?id=2627300634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627300634?lang=en_us&edition=fundamental","pubTime":"2026-04-13 20:00","pubTimestamp":1776081603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA8DDZNC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627300554","title":"Septerna Inc - Phase 1 Trial Data Expected in Late 2026 or Early 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2627300554","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627300554?lang=en_us&edition=fundamental","pubTime":"2026-04-13 20:00","pubTimestamp":1776081603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA8DDZNC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SEPN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622097613","title":"Septerna Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2622097613","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622097613?lang=en_us&edition=fundamental","pubTime":"2026-03-25 02:22","pubTimestamp":1774376520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SEPN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 24, 2026 14:22 ET (18:22 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621970257","title":"Should Septerna’s New ATM and Shelf Offering Strategy Require Action From Septerna (SEPN) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2621970257","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621970257?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:07","pubTimestamp":1774274841,"startTime":"0","endTime":"0","summary":"Earlier in March 2026, Septerna, Inc. reported full-year 2025 results showing sales of US$45.95 million and a narrower net loss of US$48.88 million, followed by a filing for a US$150 million at-the-market follow-on equity offering.\nOn the same date, the company also registered an omnibus shelf covering common and preferred stock, debt securities, warrants and units, giving it broad flexibility to raise capital across multiple instruments over time.\nNext, we’ll examine how Septerna’s new...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/should-septernas-new-atm-and-shelf-offering-strategy-require","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/should-septernas-new-atm-and-shelf-offering-strategy-require","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","SEPN","BK4007","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619291464","title":"Septerna (SEPN) Is Down 13.5% After Launching US$150 Million ATM Equity Program and Filing Shelves","url":"https://stock-news.laohu8.com/highlight/detail?id=2619291464","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619291464?lang=en_us&edition=fundamental","pubTime":"2026-03-16 21:10","pubTimestamp":1773666655,"startTime":"0","endTime":"0","summary":"Earlier in March 2026, Septerna, Inc. filed an omnibus shelf registration covering common and preferred stock, debt securities, warrants and units, alongside a separate ESOP-related shelf for 3,109,715 common shares valued at about US$89.50 million.\nThe company also reported full-year 2025 results, with sales increasing to US$45.95 million and net loss narrowing to US$48.88 million, while simultaneously announcing a US$150 million at-the-market follow-on equity offering that could materially...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/septerna-sepn-is-down-135-after-launching-us150-million-atm","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/septerna-sepn-is-down-135-after-launching-us150-million-atm","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","SEPN","EQR","BK4588","BK4215","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181266667","title":"Stock Track | Septerna Plummets 5.05% Intraday as Q4 Losses Reinforce Profitability Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1181266667","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181266667?lang=en_us&edition=fundamental","pubTime":"2026-03-12 02:59","pubTimestamp":1773255545,"startTime":"0","endTime":"0","summary":"Septerna, Inc. (SEPN) saw its stock price drop 5.05% during intraday trading on Wednesday, following the release of its fourth-quarter financial results that showed continued losses despite...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618925983","title":"Septerna (SEPN) Q4 Loss Despite Revenue Surge Reinforces Bearish Profitability Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2618925983","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618925983?lang=en_us&edition=fundamental","pubTime":"2026-03-11 22:13","pubTimestamp":1773238439,"startTime":"0","endTime":"0","summary":"Septerna (SEPN) just closed out FY 2025 with Q4 revenue of US$24.1 million, a basic EPS loss of US$0.24 and quarterly net income excluding extra items showing a loss of US$10.7 million, while trailing twelve month revenue reached US$46.0 million and EPS was a loss of US$1.10. Over the past few quarters, the company has seen revenue move from US$0.21 million in Q4 FY 2024 to US$24.1 million in Q4 FY 2025. Basic EPS ranged from a loss of US$0.64 in Q4 FY 2024 to a profit of US$0.18 in Q3 FY...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/septerna-sepn-q4-loss-despite-revenue-surge-reinforces-beari","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/septerna-sepn-q4-loss-despite-revenue-surge-reinforces-beari","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618235469","title":"Septerna Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2618235469","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618235469?lang=en_us&edition=fundamental","pubTime":"2026-03-11 22:03","pubTimestamp":1773237780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SEPN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2026 10:03 ET (14:03 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618944256","title":"Septerna price target raised to $35 from $34 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2618944256","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618944256?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:51","pubTimestamp":1773229918,"startTime":"0","endTime":"0","summary":"Truist analyst Srikripa Devarakonda raised the firm’s price target on Septerna (SEPN) to $35 from $34 and keeps a Buy rating on the shares. The fir...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/septerna-price-target-raised-to-35-from-34-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/septerna-price-target-raised-to-35-from-34-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618451849","title":"Truist Lifts Price Target on Septerna to $35 From $34, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2618451849","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618451849?lang=en_us&edition=fundamental","pubTime":"2026-03-11 18:22","pubTimestamp":1773224576,"startTime":"0","endTime":"0","summary":"Septerna (SEPN) has an average rating of buy and mean price target of $45.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618961332","title":"Septerna files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2618961332","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618961332?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:35","pubTimestamp":1773174929,"startTime":"0","endTime":"0","summary":"16:33 EDT Septerna (SEPN) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/septerna-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/septerna-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618934960","title":"Wells Fargo Reaffirms Their Buy Rating on Septerna, Inc. (SEPN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618934960","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618934960?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:58","pubTimestamp":1773140313,"startTime":"0","endTime":"0","summary":"In a report released today, Derek Archila from Wells Fargo reiterated a Buy rating on Septerna, Inc., with a price target of $48.00. According to T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-reaffirms-their-buy-rating-on-septerna-inc-sepn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-reaffirms-their-buy-rating-on-septerna-inc-sepn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618604323","title":"Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2618604323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618604323?lang=en_us&edition=fundamental","pubTime":"2026-03-10 09:45","pubTimestamp":1773107121,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Yaron Werber has maintained their bullish stance on SEPN stock, giving a Buy rating on March 3. Yaron Werber has given his Buy rat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/septerna-novo-backed-gpcr-platform-and-best-in-class-potential-for-oral-mrgprx2-inhibitor-sep-631-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/septerna-novo-backed-gpcr-platform-and-best-in-class-potential-for-oral-mrgprx2-inhibitor-sep-631-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618721846","title":"Septerna reports Q4 EPS (24c), consensus (22c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618721846","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618721846?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:40","pubTimestamp":1773088812,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $24.12M, consensus $15.56M. “We made significant strides advancing our pipeline in the past year, and 2026 has already delivered...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/septerna-reports-q4-eps-24c-consensus-22c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/septerna-reports-q4-eps-24c-consensus-22c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618674208","title":"Biotech firm Septerna beats Q4 revenue expectations, net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2618674208","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618674208?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:22","pubTimestamp":1773087779,"startTime":"0","endTime":"0","summary":"Biotech firm Septerna beats Q4 revenue expectations, net loss narrowsOverviewBiotechnology firm's Q4 revenue beat analyst expectationsCompany reported net loss of $10.7 mln for Q4, down from $20.7 mln","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL1N3ZX14H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618747626","title":"Earnings Flash (SEPN) Septerna Posts Q4 Loss $-0.24, vs. FactSet Est of Loss of $-0.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2618747626","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618747626?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:22","pubTimestamp":1773087766,"startTime":"0","endTime":"0","summary":"Earnings Flash (SEPN) Septerna Posts Q4 Loss $-0.24, vs. FactSet Est of Loss of $-0.24","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618674991","title":"Septerna Q4 EPS $(0.24) Misses $0.03 Estimate, Sales $24.118M Miss $32.667M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2618674991","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618674991?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:14","pubTimestamp":1773087265,"startTime":"0","endTime":"0","summary":"Septerna (NASDAQ:SEPN) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $0.03 by 988.89 percent. This is a 62.5 percent increase over losses of $(0.64) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51143450/septerna-q4-eps-0-24-misses-0-03-estimate-sales-24-118m-miss-32-667m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Septerna Q4 EPS $(0.24) Misses $0.03 Estimate, Sales $24.118M Miss $32.667M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618674890","title":"Septerna Q4 revenue hits USD 24.12 million as net loss narrows 48% to USD 10.74 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618674890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618674890?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:05","pubTimestamp":1773086746,"startTime":"0","endTime":"0","summary":"Septerna reported Q4 revenue of USD 24.12 million and a Q4 net loss of USD 10.74 million. R&D expenses rose 65% to USD 31.86 million, while G&A expenses increased 48% to USD 8.28 million. For FY 2025, revenue was USD 45.95 million and net loss was USD 48.88 million. FY R&D expenses increased 49% to USD 97.58 million and FY G&A expenses rose 76% to USD 29.16 million. Cash, cash equivalents and marketable securities totaled USD 548.66 million at year-end, and management said its cash runway is expected to fund operations at least into 2029.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL5WcZ2s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SG9999014005.SGD","SG9999014021.USD","LU2095319765.USD","SG9999014013.SGD","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","NDAQ","SEPN","BK4588","BK4585","BK4112","IE00BKPKM429.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":81,"code":"91000000","status":"200"}]}}